Mölnlycke Health Care announces USD 8 million investment in diabetic foot ulcer management system company Siren January 8, 2025
SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD) December 16, 2024
